Latest news
Loading news…
BioStrand
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Diepenbeek, Limburg, Belgium Founded 2019 11-50 employees For Profit
BioStrand is advancing technology for analyzing genetic data, which will drive innovation in the fields of precision medicine.
BioStrand was acquired by ImmunoPrecise Antibodies in 2022 for $22M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
7
Patents
1
2 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 10
- Patents granted
- 1
- Trademarks
- 2
- IT spend
- $9M
Company Info
- Founded
- 2019
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 32
- HQ
- Diepenbeek, Limburg, Belgium
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Mar 29, 2022
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -0.3
- Trend (90d)
- 0.9
Key People at BioStrand
Chief Commercial Officer
Co-Founder and CEO
CTO and Co- founder
7
professional contacts at BioStrand
Contact execs at BioStrand →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to BioStrand
Loading news…
FAQs about BioStrand
People who checked this page also checked these
Browse the full Acquirezy directory.